Pharmacogenomics of anthracycline-induced cardiotoxicity in children with cancer
- Conditions
- heart damage cardiotoxicity10019280
- Registration Number
- NL-OMON33355
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Diagnosis of childhood cancer and treatment with anthracyclines
Decreased heart function and normal heart function
Age: at least 18 years old
Exclusion Criteria
Age: below 18 years
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method